Adenosine effects upon the spontaneous quantal transmitter release at the frog neuromuscular junction in the presence of protein kinase C-blocking and -activating agents

Neurosci Lett. 1989 Mar 13;98(1):96-100. doi: 10.1016/0304-3940(89)90380-7.

Abstract

This paper gives experimental evidence involving protein kinase C (PKC) in the inhibitory effects of adenosine (ADO) upon the spontaneous transmitter release at the frog neuromuscular junction. In the presence of two PKC inhibitors--polymyxin B (5 x 10(-6) mol/l) and H-7 (10(-5) mol/l), both adenosine (5 x 10(-5) mol/l) and its stable analogue 1-PIA (5 x 10(-8) mol/l), significantly increased the rate of the spontaneous release of acetylcholine quanta. Even when PKC was activated with OAG (5 x 10(-6) mol/l) or TPA (162 x 10(-9) mol/l) and quantal release was increased greatly, ADO still inhibited release. ADO deaminase increased the PKC-induced activation of the transmitter release significantly.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Acetylcholine / metabolism*
  • Acetylcholine / physiology
  • Adenosine / pharmacology*
  • Animals
  • Diglycerides / pharmacology*
  • Glycerides / pharmacology*
  • In Vitro Techniques
  • Isoquinolines / pharmacology
  • Neuromuscular Junction / drug effects
  • Neuromuscular Junction / metabolism*
  • Neuromuscular Junction / physiology
  • Piperazines / pharmacology
  • Polymyxin B / pharmacology*
  • Polymyxins / pharmacology*
  • Protease Inhibitors / pharmacology
  • Protein Kinase C / metabolism
  • Protein Kinase C / physiology*
  • Rana ridibunda

Substances

  • Diglycerides
  • Glycerides
  • Isoquinolines
  • Piperazines
  • Polymyxins
  • Protease Inhibitors
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • 1-oleoyl-2-acetylglycerol
  • Protein Kinase C
  • Polymyxin B
  • Adenosine
  • Acetylcholine